Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

Market Cap	4.22B
Revenue (ttm)	1.33B
Net Income (ttm)	41.80M
Shares Out	611.69M
EPS (ttm)	0.07
PE Ratio	101.33
Forward PE	n/a
Dividend	0.08 (1.16%)
Ex-Dividend Date	Jul 11, 2024

Volume	16,059,666
Average Volume	43,067,894
Open	6.92
Previous Close	6.90
Day's Range	6.83 - 7.09
52-Week Range	3.90 - 9.12
Beta	0.68
RSI	52.19
Earnings Date	Aug 29, 2025

About SHE:002082

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through Pharmaceutical Production and Sales, and Medical Equipment and Personal Equipment Production and Sale segments. It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases. The company also develops and sells ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 1,499
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002082

Financial Performance

In 2024, SHE:002082's revenue was 1.44 billion, a decrease of -6.39% compared to the previous year's 1.54 billion. Earnings were 55.44 million, an increase of 12.66%.